Younis MH[au] - Search Results

Year	Number of Results
2007	1
2011	3
2013	1
2015	2
2016	2
2017	2
2018	6
2019	7
2020	4
2021	9
2022	19
2023	4
2024	3

1

Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond.

Li M, Younis MH, Zhang Y, Cai W, Lan X. Li M, et al. Among authors: younis mh. Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2844-2868. doi: 10.1007/s00259-022-05706-y. Epub 2022 Jan 31. Eur J Nucl Med Mol Imaging. 2022. PMID: 35098327 Free PMC article. Review.

2

DNMT3B-mediated FAM111B methylation promotes papillary thyroid tumor glycolysis, growth and metastasis.

Zhu X, Xue C, Kang X, Jia X, Wang L, Younis MH, Liu D, Huo N, Han Y, Chen Z, Fu J, Zhou C, Yao X, Du Y, Cai W, Kang L, Lyu Z. Zhu X, et al. Among authors: younis mh. Int J Biol Sci. 2022 Jul 4;18(11):4372-4387. doi: 10.7150/ijbs.72397. eCollection 2022. Int J Biol Sci. 2022. PMID: 35864964 Free PMC article.

3

Next-Generation Molecular Imaging of Thyroid Cancer.

Jin Y, Liu B, Younis MH, Huang G, Liu J, Cai W, Wei W. Jin Y, et al. Among authors: younis mh. Cancers (Basel). 2021 Jun 25;13(13):3188. doi: 10.3390/cancers13133188. Cancers (Basel). 2021. PMID: 34202358 Free PMC article. Review.

4

Spectral computed tomography with inorganic nanomaterials: State-of-the-art.

Li Y, Younis MH, Wang H, Zhang J, Cai W, Ni D. Li Y, et al. Among authors: younis mh. Adv Drug Deliv Rev. 2022 Oct;189:114524. doi: 10.1016/j.addr.2022.114524. Epub 2022 Sep 2. Adv Drug Deliv Rev. 2022. PMID: 36058350 Free PMC article. Review.

5

Single-Domain Antibody Theranostics on the Horizon.

Wei W, Younis MH, Lan X, Liu J, Cai W. Wei W, et al. Among authors: younis mh. J Nucl Med. 2022 Oct;63(10):1475-1479. doi: 10.2967/jnumed.122.263907. Epub 2022 Jul 14. J Nucl Med. 2022. PMID: 35835579 Free PMC article.

6

Catalytic radiosensitization: Insights from materials physicochemistry.

Wang Y, Zhang H, Liu Y, Younis MH, Cai W, Bu W. Wang Y, et al. Among authors: younis mh. Mater Today (Kidlington). 2022 Jul-Aug;57:262-278. doi: 10.1016/j.mattod.2022.05.022. Epub 2022 Jun 16. Mater Today (Kidlington). 2022. PMID: 36425004 Free PMC article.

7

High-performance renal imaging with a radiolabeled, non-excretable chimeric fusion protein.

Jiang D, Younis MH, Lan X, Cai W. Jiang D, et al. Among authors: younis mh. Theranostics. 2021 Sep 3;11(18):9177-9179. doi: 10.7150/thno.66417. eCollection 2021. Theranostics. 2021. PMID: 34522233 Free PMC article.

8

Enhancing fibroblast activation protein (FAP)-targeted radionuclide therapy with albumin binding, and beyond.

Younis MH, Malih S, Lan X, Rasaee MJ, Cai W. Younis MH, et al. Eur J Nucl Med Mol Imaging. 2022 May;49(6):1773-1777. doi: 10.1007/s00259-022-05766-0. Eur J Nucl Med Mol Imaging. 2022. PMID: 35332379 Free PMC article. No abstract available.

9

Multimodality imaging of nanoparticle-based vaccines: Shedding light on immunology.

Younis MH, Tang Z, Cai W. Younis MH, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Sep;14(5):e1807. doi: 10.1002/wnan.1807. Epub 2022 May 2. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022. PMID: 35501142 Free PMC article. Review.

10

ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer.

Chen W, Li M, Younis MH, Barnhart TE, Jiang D, Sun T, Lang JM, Engle JW, Zhou M, Cai W. Chen W, et al. Among authors: younis mh. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):861-870. doi: 10.1007/s00259-021-05563-1. Epub 2021 Sep 14. Eur J Nucl Med Mol Imaging. 2022. PMID: 34519889 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

50 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year